Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Symptomatic Anemia”

32 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 32 results

Early research (Phase 1)Study completedNCT02241200
What this trial is testing

A Study in Healthy Volunteers to Compare the Profiles of DA-3880 and EU Sourced ARANESP® (Amgen)

Who this might be right for
Symptomatic Anemia
Dong-A ST Co., Ltd. 64
Not applicableStudy completedNCT02140736
What this trial is testing

Epoetin Alfa Biosimilar in the Management of Chemotherapy-Induced Symptomatic Anemia in Haematology and Oncology

Who this might be right for
Chemotherapy-induced Symptomatic AnemiaSolid TumorsMalignant Hemopathies+2 more
Hospira, now a wholly owned subsidiary of Pfizer 2,333
Large-scale testing (Phase 3)Active Not RecruitingNCT00843882
What this trial is testing

Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia

Who this might be right for
AnemiaChronic Myelomonocytic LeukemiaDe Novo Myelodysplastic Syndrome+1 more
National Cancer Institute (NCI) 247
Post-approval studies (Phase 4)Study completedNCT02434952
What this trial is testing

Safety and Tolerability of Low Dose Primaquine

Who this might be right for
Malaria, FalciparumG6PD Deficiency
Malaria Consortium 109
Testing effectiveness (Phase 2)Study completedNCT01772420
What this trial is testing

Phase II Study of Lenalidomide and Eltrombopag in Patients With Symptomatic Anemia

Who this might be right for
Adult Myelodysplastic SyndromeAnemiaChronic Myelomonocytic Leukemia
Albert Einstein College of Medicine 52
Not applicableStudy completedNCT00117234
What this trial is testing

Impact of Darbepoetin Alfa on Exercise Tolerance and Left Ventricular Structure in Subjects With Symptomatic Congestive Heart Failure (CHF) and Anemia

Who this might be right for
Congestive Heart FailureAnemia
Amgen
Large-scale testing (Phase 3)Ended earlyNCT00534456
What this trial is testing

An Exploratory Sub-study for the RED-HF™ (Reduction of Events With Darbepoetin Alfa in Heart Failure) Trial

Who this might be right for
AnemiaCardiovascular DiseaseCongestive Heart Failure+2 more
Amgen 12
Testing effectiveness (Phase 2)Study completedNCT00086086
What this trial is testing

Subcutaneous (SC) Darbepoetin Alfa in Subjects With Symptomatic Congestive Heart Failure (CHF) & Anemia

Who this might be right for
Congestive Heart FailureAnemia
Amgen 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT07052006
What this trial is testing

A Phase 2a Study of HT-6184 in Subjects With IPSS-R Very Low, Low or Intermediate Risk MDS and Anemia

Who this might be right for
Myelodysplastic SyndromeAnemia in Myelodysplastic Syndromes
Halia Therapeutics, Inc. 37
Not applicableStudy completedNCT01626547
What this trial is testing

Biosimilar Retacrit™ (Epoetin Zeta) in the Treatment of Chemotherapy-Induced Symptomatic Anaemia in Haematology and Oncology

Who this might be right for
Chemotherapy-induced Symptomatic AnaemiaSolid TumoursMalignant Lymphomas+1 more
Hospira, now a wholly owned subsidiary of Pfizer 291
Large-scale testing (Phase 3)Study completedNCT00358215
What this trial is testing

RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial

Who this might be right for
Heart FailureAnemiaCardiovascular Disease+2 more
Amgen 2,278
Not applicableEnrolling By InvitationNCT03655223
What this trial is testing

Early Check: Expanded Screening in Newborns

Who this might be right for
Spinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more
RTI International 30,000
Large-scale testing (Phase 3)Study completedNCT02390102
What this trial is testing

Erythropoietin + Iron Therapy for Anemic Patients Undergoing Aortic Valve Replacement

Who this might be right for
AnemiaAortic Stenosis
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec 117
Testing effectiveness (Phase 2)UnknownNCT03247218
What this trial is testing

A Phase - IIa - IIb, Trial to Study the Safety, Tolerability and Efficacy of Memantine as a Long-term Treatment of SCD

Who this might be right for
Sickle Cell Disease
HaEmek Medical Center, Israel 40
Not applicableStudy completedNCT01809314
What this trial is testing

An Observational Study of Epoetin Beta (NeoRecormon) in Participants With Cancer Receiving Chemotherapy

Who this might be right for
Anemia
Hoffmann-La Roche 1,167
Large-scale testing (Phase 3)Study completedNCT00144755
What this trial is testing

R-CHOP-14 Versus R-CHOP-21 and Darbepoetin Alpha in Patients Aged 60-80 Years With Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large Cell Lymphoma
Lymphoma Study Association 600
Testing effectiveness (Phase 2)Study completedNCT00812968
What this trial is testing

Study of CC-5013 to Evaluate Safety, Pharmacokinetics and Effectiveness for Japanese Patients With Symptomatic Anemia Associated With Myelodysplastic Syndrome With a Del(5)(q31-33) Abnormality.

Who this might be right for
Myelodysplastic Syndromes
Celgene 11
Early research (Phase 1)Study completedNCT04439006
What this trial is testing

Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization

Who this might be right for
Aplastic AnemiaHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm+4 more
Jennifer Woyach 10
Testing effectiveness (Phase 2)Study completedNCT00049985
What this trial is testing

Heart Failure and Anemia

Who this might be right for
Heart FailureAnemia
Amgen 300
Large-scale testing (Phase 3)Ended earlyNCT00310830
What this trial is testing

Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients With Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Hypertension
Actelion 14
Load More Results